Medicinova MNOV
NASDAQ MNOV
$1.36 -0.02 (-1.45%)
At close: Aug 20, 2026 · 4:00 PM EDT

Medicinova (MNOV) Debt Ratio (2010)

Medicinova (MNOV) posted quarterly Debt Ratio of 0.2 for Q4 2010.

Medicinova (MNOV) Debt Ratio (2010) Analysis & Trends

Medicinova (MNOV) has reported Debt Ratio for 1 consecutive years, with 0.2 the latest figure, recorded in Q4 2010.

  • In Q4 2010, Debt Ratio changed N/A year-over-year to 0.2; the TTM figure through Dec 2010 stood at 0.2 (changed N/A YoY), while the FY2010 annual figure was 0.2, changed N/A from the prior year.
  • Debt Ratio was little changed at 0.2 in Q4 2010 per MNOV's latest filing.
  • Across five years, Debt Ratio topped out at 0.2 in Q4 2010 and bottomed at 0.2 in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.05
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.26
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.47
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.03
10 Medicinova 66.94 Mn 66.94 Mn 317,759.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 0.20